Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341)

Kaiwen Wang, Jiangfeng Zhao, Zhiwei Chen, Ting Li, Xiaoming Tan, Yu Zheng, Liyang Gu, Li Guo, Fangfang Sun, Haiting Wang, Jiajie Li, Xiaodong Wang, Gabriela Riemekasten, Shuang Ye*

*Corresponding author for this work
1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341)'. Together they form a unique fingerprint.

Medicine & Life Sciences